| 000 | 01537 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513061354.0 | ||
| 264 | 0 | _c19930902 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0012-3692 | ||
| 024 | 7 |
_a10.1378/chest.104.2.481 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCapelli, A | |
| 245 | 0 | 0 |
_aIn vitro effect of beta 2-agonists on bacterial killing and superoxide anion (O2-) release from alveolar macrophages of patients with chronic bronchitis. _h[electronic resource] |
| 260 |
_bChest _cAug 1993 |
||
| 300 |
_a481-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuterol _xpharmacology |
| 650 | 0 | 4 |
_aBronchitis _xphysiopathology |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthanolamines _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFormoterol Fumarate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMacrophages, Alveolar _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xphysiology |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 700 | 1 | _aLusuardi, M | |
| 700 | 1 | _aCarli, S | |
| 700 | 1 | _aZaccaria, S | |
| 700 | 1 | _aTrombetta, N | |
| 700 | 1 | _aDonner, C F | |
| 773 | 0 |
_tChest _gvol. 104 _gno. 2 _gp. 481-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.104.2.481 _zAvailable from publisher's website |
| 999 |
_c8101119 _d8101119 |
||